Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cnicus benedictus
Herbe médiévale européenne utilisée par les moines pour les bitters digestifs, le traitement de la fièvre et des éruptions cutanées, et comme galactogène.
Blessed Thistle (Cnicus benedictus) is a medieval European herb traditionally used as a digestive bitter tonic, galactagogue, and for fever treatment. Its primary active compounds include the bitter sesquiterpene lactone cnicin, polyacetylenes, flavonoids, and tannins, which contribute to its digestive, anti-inflammatory, and lactation-supporting properties. Modern evidence is limited (Level C), supporting its use as a digestive bitter and anti-inflammatory agent.
Cnicin stimulates bitter taste receptors (T2Rs) on the tongue and in the gastrointestinal tract, leading to increased gastric acid secretion, bile flow, and digestive enzyme release via vagal reflexes. Polyacetylenes inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby exerting anti-inflammatory effects. Flavonoids provide antioxidant activity by scavenging free radicals and modulating NF-κB signaling. The galactagogue effect is hypothesized to involve prolactin elevation or direct mammary gland stimulation, though specific receptor pathways remain unconfirmed.
Herbe médiévale européenne utilisée par les moines pour les bitters digestifs, le traitement de la fièvre et des éruptions cutanées, et comme galactogène.
Blessed Thistle (Cnicus benedictus) is a medieval European herb traditionally used as a digestive bitter tonic, galactagogue, and for fever treatment. Its primary active compounds include the bitter sesquiterpene lactone cnicin, polyacetylenes, flavonoids, and tannins, which contribute to its digestive, anti-inflammatory, and lactation-supporting properties. Modern evidence is limited (Level C), supporting its use as a digestive bitter and anti-inflammatory agent.
Cnicin stimulates bitter taste receptors (T2Rs) on the tongue and in the gastrointestinal tract, leading to increased gastric acid secretion, bile flow, and digestive enzyme release via vagal reflexes. Polyacetylenes inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby exerting anti-inflammatory effects. Flavonoids provide antioxidant activity by scavenging free radicals and modulating NF-κB signaling. The galactagogue effect is hypothesized to involve prolactin elevation or direct mammary gland stimulation, though specific receptor pathways remain unconfirmed.